Form 4: Senseonics Director Douglas Prince Receives Equity Grant

Director Douglas S. Prince was granted restricted stock units and stock options as part of the company's non-employee director compensation policy.

Summary

• Director Douglas S. Prince acquired 9,852 restricted stock units (RSUs) on May 20, 2026.
• The director also received a grant of 13,574 stock options with an exercise price of $5.71 per share.
• Both the RSUs and stock options vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting.
• Following these transactions, the director's direct beneficial ownership of common stock increased to 67,816 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices with no material impact on company operations.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized compensation structure under the company's non-employee director policy.

Negatives

• Dilutive impact of new equity grants on existing shareholders, though minor in scale.

Risks

• Vesting is contingent upon the director's continuous service to the company.

Future Outlook

The equity grants are subject to standard vesting conditions tied to the director's continued service over the next year.

Industry Context

StockSavvy.ai notes that this filing represents routine corporate governance activity regarding director compensation, which is standard practice for publicly traded medical technology companies to ensure board retention and alignment.

Comparison to Industry Standards

• The use of RSUs and stock options for non-employee directors is consistent with standard compensation practices for mid-cap healthcare and technology firms.
• Vesting schedules of one year are typical for director equity compensation to ensure alignment with annual meeting cycles.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders due to the small volume of equity granted relative to total outstanding shares.

Next Steps

• Vesting of equity grants on the earlier of May 20, 2027, or the next annual stockholders meeting.

Key Dates

Keywords

Senseonics, SENS, Director Compensation, Equity Grant, Insider Transaction, Form 4